Catch me if you can: how AML and its niche escape immunotherapy

S Tettamanti, A Pievani, A Biondi, G Dotti, M Serafini - Leukemia, 2022 - nature.com
In spite of the remarkable progress in basic and preclinical studies of acute myeloid
leukemia (AML), the five-year survival rate of AML patients remains poor, highlighting the …

Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy

T Sauerer, GF Velázquez, C Schmid - Molecular Cancer, 2023 - Springer
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the expansion
of immature myeloid cells in the bone marrow (BM) and peripheral blood (PB) resulting in …

Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy

D Forte, M García-Fernández, A Sanchez-Aguilera… - Cell metabolism, 2020 - cell.com
Like normal hematopoietic stem cells, leukemic stem cells depend on their bone marrow
(BM) microenvironment for survival, but the underlying mechanisms remain largely …

The cytokine network in acute myeloid leukemia (AML): A focus on pro-and anti-inflammatory mediators

S Binder, M Luciano, J Horejs-Hoeck - Cytokine & growth factor reviews, 2018 - Elsevier
Cytokines exert profound effects on the progression of hematopoietic malignancies such as
acute myeloid leukemia (AML). Critical roles of cytokines in the context of inflammation have …

[HTML][HTML] Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities

E O'Reilly, HA Zeinabad, E Szegezdi - Blood Reviews, 2021 - Elsevier
Hematopoietic stem cells (HSC) are responsible for the production of mature blood cells. To
ensure that the HSC pool does not get exhausted over the lifetime of an individual, most …

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia …

M Azadniv, JR Myers, HR McMurray, N Guo, P Rock… - Leukemia, 2020 - nature.com
Bone marrow mesenchymal stromal cells (MSCs) constitute one of the important
components of the hematopoietic microenvironmental niche. In vivo studies have shown that …

Acute myeloid leukemia cells educate mesenchymal stromal cells toward an adipogenic differentiation propensity with leukemia promotion capabilities

L Zhang, Q Zhao, H Cang, Z Wang, X Hu… - Advanced …, 2022 - Wiley Online Library
Mesenchymal stromal cells (MSCs) are essential elements of the bone marrow (BM)
microenvironment, which have been widely implicated in pathways that contribute to …

Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery

G Almeida-Porada, AJ Atala, CD Porada - Molecular Therapy-Methods & …, 2020 - cell.com
Mesenchymal stromal cells (MSCs) possess several fairly unique properties that, when
combined, make them ideally suited for cellular-based immunotherapy and as vehicles for …

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support …

G Corradi, C Baldazzi, D Očadlíková, G Marconi… - Stem cell research & …, 2018 - Springer
Abstract Background Mesenchymal stromal cells (MSCs) are an essential element of the
bone marrow (BM) microenvironment, playing a crucial function in regulating hematopoietic …

Tumor microenvironment in acute myeloid leukemia: adjusting niches

T Menter, A Tzankov - Frontiers in Immunology, 2022 - frontiersin.org
Acute myeloid leukemias (AML) comprise a wide array of different entities, which have in
common a rapid expansion of myeloid blast cells leading to displacement of normal …